Overview

Efficacy and Safety of HU007 Eye Drops in Patients With Dry Eye Syndrome

Status:
Completed
Trial end date:
2018-07-12
Target enrollment:
Participant gender:
Summary
A multicenter, Randomized, Double blind, Restasis®-controlled Non-inferiority, Moisview® Eye Drops-controlled Superiority, Phase III Study to Evaluate the Efficacy and Safety of HU007 Eye Drops in Patients with Dry Eye Syndrome
Phase:
Phase 3
Details
Lead Sponsor:
Huons Co., Ltd.
Huons Co.,Ltd.
Treatments:
Cyclosporine
Cyclosporins
Ophthalmic Solutions